Xaira Therapeutics
CA - South SFBiotechnology
Focus: Xaira Therapeutics is an AI-driven drug discovery company founded in 2024, focused on leveraging artificial intelligence to identify novel therapeutics across ophthalmology, neurology, and gene therapy. The company is pre-revenue and in early-stage operations.
Profile data last refreshed 3h ago · AI intelligence enriched 2w ago
Open Jobs
17+2 this month
Stable — net +2 jobs in 30d
6 added, 4 removed. Backfill posture.
Should You Work at Xaira Therapeutics?
AI assessmentXaira is a high-risk, high-reward early-stage play best suited for scientists and engineers seeking equity upside and methodological innovation, not stability.
Why Work Here
- Ground-floor opportunity at a 2024-founded AI drug discovery platform with potential to reshape drug development across high-value therapeutic areas
- Balanced hiring across core AI/ML (Data Science, High Throughput Biology) and translational capabilities suggests serious scientific infrastructure, not just a software shop
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Xaira Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.